We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
SOPH icon
176
SOPHiA GENETICS
SOPH
$650M
$650M $7.63 1.73%
STLN
177
Starling Oncology
STLN
$644M
$644M $6.32 2.02%
KIDS icon
178
OrthoPediatrics
KIDS
$642M
$642M $24.60 0.81%
ANGO icon
179
AngioDynamics
ANGO
$641M
$641M $15.50 2.21%
ASMB icon
180
Assembly Biosciences
ASMB
$637M
$637M $31.30 5.01%
TLRY icon
181
Tilray
TLRY
$630M
$630M $4.58 1.93%
VSTM icon
182
Verastem
VSTM
$629M
$629M $6.94 5.47%
NVCT icon
183
Nuvectis Pharma
NVCT
$622M
$622M $19.10 0.74%
CTEV
184
Claritev Corp
CTEV
$617M
$617M $36.42 4.46%
BWAY
185
Brainsway
BWAY
$617M
$617M $15.38 5.76%
CRMD icon
186
CorMedix
CRMD
$617M
$617M $7.91 4.91%
MDXG icon
187
MiMedx Group
MDXG
$614M
$614M $4.21 1.41%
CTKB icon
188
Cytek Biosciences
CTKB
$611M
$611M $4.70 0.21%
AUTL
189
Autolus Therapeutics
AUTL
$609M
$609M $2.29 6.51%
ARVN icon
190
Arvinas
ARVN
$598M
$598M $9.15 2.01%
CERS icon
191
Cerus
CERS
$597M
$597M $2.96 0.67%
SPRY icon
192
ARS Pharmaceuticals
SPRY
$590M
$590M $5.93 4.96%
DCTH icon
193
Delcath Systems
DCTH
$583M
$583M $16.80 0.42%
ALT icon
194
Altimmune
ALT
$580M
$580M $2.98 1.36%
OABI icon
195
OmniAb
OABI
$579M
$579M $3.98 17.8%
ARTV
196
Artiva Biotherapeutics
ARTV
$575M
$575M $11.77 2.79%
PRME icon
197
Prime Medicine
PRME
$573M
$573M $3.16 2.27%
EIKN
198
Eikon Therapeutics
EIKN
$569M
$569M $10.51 4.89%
CTNM
199
Contineum Therapeutics
CTNM
$559M
$559M $14.85 4.65%
OVID icon
200
Ovid Therapeutics
OVID
$555M
$555M $2.84 0.35%
6 7
8
9 10

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 321 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $275B.

The largest by market cap are Zenas BioPharma (ZBIO) at $1.98B, Generate Biomedicines (GENB) at $1.95B and Progyny (PGNY) at $1.95B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 148 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.